Loading...
XCNQ
CXXI
Market cap32mUSD
Aug 20, Last price  
0.39CAD
Name

C21 Investments Inc

Chart & performance

D1W1MN
XCNQ:CXXI chart
P/E
—
P/S
0.99
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.44%
Rev. gr., 5y
-0.35%
Revenues
32m
+7.60%
109,464249,196139,449142,802132,3440000002,586,00037,705,00033,466,00032,983,00028,888,00028,285,00030,117,88030,117,88032,406,320
Net income
-3m
L-18.81%
0-1,316,0000-623,0000-733,000-365,000000-631,000-23,601,000-32,556,000-8,205,0009,955,000293,211-3,305,000-3,969,542-3,969,542-3,223,011
CFO
1m
+21.04%
012,02500015,739000000-11,366,8535,509,8649,923,7256,836,1315,899,9755,899,9751,189,1661,439,367

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C21 Investments Inc. operates as a comprehensive enterprise within the cannabis sector, handling the cultivation, processing, distribution, and retail of consumer goods derived from cannabis and hemp throughout the United States. Its diverse product lineup includes both pre-packaged and bulk cannabis flower, vaporizer cartridges, concentrated extracts, edible products, pre-rolled joints, liquid tinctures, and topical applications. In addition, the company provides payroll administration and employee benefits solutions. Originally incorporated in 1987, the firm rebranded to C21 Investments Inc. in November 2017, having previously operated under the name Curlew Lake Resources Inc. Its primary corporate headquarters are situated in Vancouver, Canada.

Key people

Sonny Newman
President, Chief Executive Officer · since 2019
Michael Kidd
Chief Financial Officer, Corporate Secretary, Director · since 2018
Aron Swan
Chief Operating Officer · since 2023
Todd Harrison
Director · since 2021
D. Bruce Macdonald
Independent Chairman of the Board · since 2020
Leonard Werden
Independent Director · since 2021
IPO date
Jun 18, 2018
Employees
116
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122025‑032025‑012024‑012023‑012022‑012021‑012020‑012019‑012018‑012017‑01
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT